Schrodinger Inc (SDGR)
Schrodinger, Inc. is a healthcare technology company listed on NASDAQ under the ticker SDGR. The company develops a physics-based computational platform used to support discovery of novel molecules for drug development and materials applications across the United States and other regions, including Asia-Pacific, Europe, the Middle East and Africa. Its operations are organized into two segments. The Software segment provides tools used in molecular discovery for life sciences and materials science applications, while the Drug Discovery segment works on preclinical and clinical programs both internally and through collaborations. Schrodinger also has a research collaboration and license agreement with Novartis Pharma AG focused on advancing multiple development candidates. The company was incorporated in 1990 and is headquartered in New York, New York.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SDGR
|
$14.99
|
-0.7% Downside
|
Fair
|
$20.57
|
36.3% Upside
|
Undervalued
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 5, 2026
|
-10.9x
|
3.6x
|
4.4x
|
1.121 B
|
800.2 M
|
8.7%
|
77.2%
|
0.7
|
—
|
143.4%
|
